Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply chains.
Patent CN114539198B reveals novel Pd-catalyzed route. Delivers cost reduction and supply chain reliability for pharmaceutical manufacturing processes globally.
Patent CN115246807B reveals novel thioester synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with high-purity output and scalable processes.
Novel Rh-catalyzed method for benzimidazo[1,2-a]quinolines using ionic liquids. High yield, additive-free process for pharma intermediates.
Patent CN106631982A enables efficient carbazole synthesis. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing for global partners.
Patent CN105936623B reveals a mild copper-catalyzed route to 3,4-cyclopentyl-1-tetralone, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel glucose-based route for trifluoromethyl triazoles. Mild conditions, high efficiency, scalable for API intermediates and fine chemicals.
Patent CN112480015B details a Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable supply chain solutions.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Patent CN115215810B reveals a catalyst-free heating method for triazole synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115385916B reveals high-yield chiral synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing globally.
Patent CN112480015B details a Pd-catalyzed one-pot method for 2-CF3 quinazolinones, offering cost reduction in pharmaceutical intermediate manufacturing via mild conditions.
Novel AlCl3-catalyzed route offers high Z-selectivity and mild conditions for scalable phthalide intermediate manufacturing.
Novel palladium-catalyzed pathway for indolone thioesters using sulfonyl chloride. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediate production significantly.
Patent CN117430549A details a green copper-catalyzed method for isonicotinic acid using CO2. Offers mild conditions and supply chain advantages for pharma intermediates.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for high-purity quinazolinone derivatives, offering significant supply chain advantages.
Novel patent CN115246757B details cost-effective Pd-catalyzed route for aryl acetamides using benzylsulfonyl chloride offering significant supply chain stability
Novel Mo/Cu co-catalyzed method offers mild conditions and high yields for critical API building blocks, ensuring supply chain stability.
Patent CN113620795B details a Rh-catalyzed C-H activation route to benzocycloheptenones. This method offers mild conditions, high yields, and scalable production for pharmaceutical intermediates.
Patent CN112480015B discloses a novel Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones. High efficiency, scalable process for API intermediates.